BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Yersinia

:Yersinia is also the name of a network tool, see Yersinia [http://www.yersinia.net/]'Yersinia is a genus of bacteria in the family Enterobacteriaceae. Yersinia are Gram-negative rod shaped bacteria, a few micrometers long and fractions of a micrometer in diameter, and are facultative anaerobes. Some members of Yersinia are pathogenic in humans. Rodents are the natural reservoirs of Yersinia; less frequently other mammals serve as the host. Infection may occur either through blood or in an alimentary fashion, through occasionally via consumption of food products contaminated with infected urine or feces.Speculations exist as to whether or not certain Yersinia can also be spread via protozoonotic mechanisms, since Yersinia are known to be facultative intracellular parasites; studies and discussions of the possibility of amoeba-vectored Yersinia propagation and proliferation are now in progress. (From the Wikpedia article Yersinia.)

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Yersinia:

Pubmed Logo
The polybasic region of Rho GTPases defines the cleavage by Yersinia enterocolitica outer protein T (YopT).
Pathogenic Yersinia strains evade the innate immune responses of the host...
28th June, 2008
Protein Sci. 2008 Jun 26;.
DOI Direct Link
Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis.
Protective antigens of Pseudomonas aeruginosa (PcrV) and Yersinia pestis...
28th June, 2008
BBSI UMR 5092, Grenoble 38054. J Biol Chem. 2008 Jun 26;.
DOI Direct Link
A new homogeneous assay for high throughput serological diagnosis of brucellosis in ruminants.
The control and eradication of brucellosis is highly desirable but heavily...
27th June, 2008
Brucella Research Group, Statutory and Exotic Bacteria, Veterinary J Immunol Methods. 2008 Jun 2;.
DOI Direct Link
Combined physico-chemical treatments based on enterocin AS-48 for inactivation of Gram-negative bacteria in soybean sprouts.
Enterocin AS-48 was tested for decontamination of soybean sprouts against...
26th June, 2008
Area de Microbiologia, Departamento de Ciencias de la Salud, Facultad de Food Chem Toxicol. 2008 Jun 6;.
DOI Direct Link
Prevalence and abundance of fleas in black-tailed prairie dog burrows: implications for the transmission of plague (Yersinia pestis).
Plague, the disease caused by the bacterium Yersinia pestis, can have...
26th June, 2008
J Parasitol. 2008 Mar 12;:1.
DOI Direct Link

View more research publications.

BioNews Results for Yersinia:

RSS Logo
BioPortfolio Logo
Vical Advances RapidResponse DNA Vaccine Platform Under $6 Million Grant from NIH
Pharma Live:  Jun 26 2008 9:24AM Matching: yersinia
Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
SmartBrief:  Jun 25 2008 11:29AM Matching: yersinia
Plague - Data on plague detailed by L. Houhamdi and co-authors
NewsRX:  Jun 23 2008 4:38PM Matching: yersinia
Plague - Studies from University of Kentucky add new findings in the area of plague
NewsRX:  Jun 23 2008 4:34PM Matching: yersinia
Plague Genetics - Research on plague genetics published by scientists at University of Toledo, Department of C
NewsRX:  Jun 19 2008 5:00PM Matching: yersinia
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Yersinia Clinical Trials:

Clinical Trials Logo
Treatment and Diagnosis of Plague
Plague Interventions: Drug: gentamicin;   Drug: streptomycin
Clinical Studies of Kikuchi's Disease
Lymphadenitis Intervention: Procedure: blood sampling, neck lymph node biopsy
One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)
Plague Interventions: Biological: Alhydrogel;   Biological: rF1 and rV protein antigens
Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V
Pneumonic Plague;   Preventive Therapy

Yersinia Patents:

USPTO Logo
US Patent No.Title
7358359 Antibacterial agents
7368547 Use of novel virulence-specific genes as targets for diagnosis and potential control of virulent strains of Listeria monocytogenes
7371385 Method of treating immune pathologies with low dose estrogen
7371388 Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7371393 Methods for reducing fecal shedding

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Yersinia scientists - we have details of around 1021 individuals working on Yersinia .


This page has been viewed 153 times
Recent Search Terms used to find this page: yscp and yscu | www.yersinia | Yersinia | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Yersinia across BioPortfolio, or bestselling Yersinia books or recently published Yersinia books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional